Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$209.01 - $232.56 $191,035 - $212,559
-914 Reduced 97.86%
20 $4,000
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $28,071 - $32,275
-142 Reduced 13.2%
934 $212,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $85,446 - $94,222
-425 Reduced 28.31%
1,076 $216,000
Q2 2023

Dec 13, 2023

SELL
$211.93 - $241.33 $847 - $965
-4 Reduced 0.27%
1,501 $362,000
Q2 2023

Aug 10, 2023

SELL
$211.93 - $241.33 $847 - $965
-4 Reduced 0.27%
1,501 $362,000
Q1 2023

Dec 13, 2023

BUY
$213.32 - $257.83 $8,106 - $9,797
38 Added 2.59%
1,505 $345,000
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $8,106 - $9,797
38 Added 2.59%
1,505 $345,000
Q4 2022

Dec 13, 2023

SELL
$203.72 - $248.97 $67,023 - $81,911
-329 Reduced 18.32%
1,467 $345,000
Q4 2022

Feb 10, 2023

SELL
$203.72 - $248.97 $67,023 - $81,911
-329 Reduced 18.32%
1,467 $345,000
Q3 2022

Dec 13, 2023

SELL
$204.81 - $262.19 $33,793 - $43,261
-165 Reduced 8.41%
1,796 $367,000
Q3 2022

Nov 08, 2022

SELL
$204.81 - $262.19 $33,793 - $43,261
-165 Reduced 8.41%
1,796 $368,000
Q2 2022

Dec 13, 2023

BUY
$213.86 - $277.87 $81,480 - $105,868
381 Added 24.11%
1,961 $459,000
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $81,480 - $105,868
381 Added 24.11%
1,961 $460,000
Q1 2022

Dec 13, 2023

BUY
$259.82 - $298.18 $130,949 - $150,282
504 Added 46.84%
1,580 $416,000
Q1 2022

May 17, 2022

BUY
$259.82 - $298.18 $410,515 - $471,124
1,580 New
1,580 $380,000
Q4 2018

May 18, 2021

SELL
$120.82 - $174.09 $164,073 - $236,414
-1,358 Closed
0 $0
Q3 2018

May 18, 2021

BUY
$167.67 - $188.27 $16,096 - $18,073
96 Added 7.61%
1,358 $236,000
Q2 2018

May 18, 2021

SELL
$160.33 - $189.41 $4,328 - $5,114
-27 Reduced 2.09%
1,262 $227,000
Q1 2018

May 18, 2021

BUY
$161.53 - $178.11 $208,212 - $229,583
1,289 New
1,289 $208,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.